1,649
Participants
Start Date
April 30, 2008
Primary Completion Date
April 30, 2009
Study Completion Date
May 31, 2009
CT Gel
Topical gel consisting of clindamycin 1% and tretinoin 0.025%, applied once daily in the evening for 12 weeks
Clindamycin Gel (clindamycin )
Clindamycin 1% gel applied topically once daily in the evening for 12 weeks
Tretinoin Gel (tretinoin)
Tretinoin 0.025% gel applied topically once daily in the evening for 12 weeks
Vehicle Gel
Topical gel without clindamycin or tretinoin applied topically once daily in the evening for 12 weeks
Yardley Dermatology Associates, Yardley
Advanced Dermatolgy & Cosemtic Surgery, Ormond Beach
FXM Research - Miramar, Miramar
FXM Research Corporation, Miami
Coastal Clinical Research, Inc., Mobile
Radiant Research, Birmingham
Tennessee Clinical Research, Nashville
Dermatology Associates of Knoxville, P.C., Knoxville
Dermatology Specialists, Louisville
Dermatology Research Associates, Inc., Cincinnati
University of Michigan, Ann Arbor
Henry Ford Medical Center, Detroit
Advanced Healthcare, Milwaukee
Minnesota Clinical Study Center, Fridley
Skin Specialists, P.C., Omaha
Burke Pharmaceutical Research, Hot Springs
The Hair and Skin Research Treatment Center, Dallas
J & S Studies, Inc., College Station
DermResearch, Inc., Austin
Longmont Medical Research Network, Longmont
Dermatology Research Center, Inc., Salt Lake City
Academic Dermatology Research, Albuquerque
University Clinical Trials, San Diego
Center for Dermatology, Cosmetic and Laser Surgery, Fremont
Premier Clincial Research, Spokane
Massachusettes General Hospital - Clinical Unit for Research Trials in Skin, Boston
Clinical Partners, LLC, Johnston
Dermatology And Skin Centre, Belize City
Dr. Moguel's Clinic, Belize City
K. Papp Clinical Research, Inc., Waterloo
Windsor Clinical Research Center, Inc., Windsor
Innovaderm Research, Inc., Montreal
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Stiefel, a GSK Company
INDUSTRY